China launches a “Two-Invoice System” to simplify the drug distribution chain and reduce prices and corruption in the healthcare sector. The new policy may bring substantial compliance and business model challenges for pharmaceutical companies
The CIRC's new draft regulations are set to change the landscape of investments in Chinese insurance companies中国保监会新发布的《保险公司股权管理办法(征求意见稿)》将改变中国保险公司的投资环境
In a rare move, the Texas judge rewrote the plea agreement to name his own independent corporate monitor in the ZTE sanctions case, substituting the DOJ's authority with the court's
The Chinese ride-hailing app company has filed a suit against former U.S. employees who allegedly used stolen trade secrets to attract investors for their own business
The SAT has increased supervision of foreign R&D institutions' tax refund eligibility, the CIRC has improved scientific assessment standards for insurance contract liabilities, and Beijing's mortgage down payment percentage has been raised to the highest among Chinese cities
The Beijing IP court overturned an infringement ruling against Apple, the central bank asked banks in the capital city to scrutinize home loans and the China-led Asian Infrastructure Investment Bank got a status boost
The CBRC has allowed foreign-invested banks to invest in domestic financial institutions, the CFDA has proposed relaxing drug trial and registration requirements, and the withdrawal procedures for a foreign partner exiting a co-operative joint venture have been eased
